Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

About this update from Microbot Medical Inc.

[{"type":"image","alt":"Microbot Medical Inc.","displaySize":"","headline":null,"caption":"Microbot Medical Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":127,"url":"https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8sc4mubv858DmIYRrwJwfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16","width":300,"height":127}},"lazy":false},{"type":"text","content":"International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular Robotics ","length":148,"tagName":"p"},{"type":"text","content":"LIBERTY® Continues to Gain Commercial Traction and Exposure as Part of Its Limited Market Release (LMR) in the US ","length":113,"tagName":"p"},{"type":"text","content":"HINGHAM, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that LIBERTY was featured at the International Symposium on Endovascular Therapy (ISET) conference, which took place February 9-12, 2026, in Miami Beach, Florida. The International Symposium on Endovascular Therapy brings together current and emerging endovascular experts to examine new techniques, technologies, and procedures that advance patient care.","length":535,"tagName":"p"},{"type":"text","content":"During a Town Hall session, titled Advances in Endovascular Robotics: Will There be a Role in the Future?, which included leading interventional radiologists, interventional cardiologists, and vascular surgeons discussing real-world clinical experience, one of the featured agenda items focused on the future of single-use handheld vascular robots, which specifically highlighted the LIBERTY Endovascular Robotic System. The LIBERTY System, the only FDA cleared, single-use endovascular robotic system, was discussed prominently, highlighting its seamless workflow integration and features, which the Company believes will be key drivers for broader adoption and shape the next phase of peripheral endovascular intervention. As procedures become more complex and operator demands are expected to continue to grow, robotic assistance offers a potential solution to challe...

More updates from Microbot Medical Inc.